Hyperlipidemia Management for Primary Care: An Evidence-Based Approach by Brian V. ReamyHyperlipidemia Management for Primary Care: An Evidence-Based Approach by Brian V. Reamy

Hyperlipidemia Management for Primary Care: An Evidence-Based Approach

EditorBrian V. Reamy

Paperback | August 8, 2008

Pricing and Purchase Info

$148.02 online 
$167.95 list price save 11%
Earn 740 plum® points

Prices and offers may vary in store


In stock online

Ships free on orders over $25

Not available in stores


This book provides multifaceted strategies necessary to treat hyperlipidemia, as well as tips for incorporating techniques into clinical practice. In addition to discussing pharmacologic treatment, the book includes a review of popular diets and therapeutic foods, herbs, and vitamins. A section on evidence-based recommendations for treating special populations discusses approaches for elderly patients, women, elite athletes, and other populations with unique medical needs. Case studies illustrate the principles introduced in the book. The text is complete with screening tools for real world risk assessment.
Title:Hyperlipidemia Management for Primary Care: An Evidence-Based ApproachFormat:PaperbackDimensions:242 pagesPublished:August 8, 2008Publisher:Springer New YorkLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:0387766057

ISBN - 13:9780387766058

Look for similar items by category:


Table of Contents

OVERVIEW OF EVIDENCE SUPPORTING TREATMENT OF HYPERLIPIDEMIA. Pre-statin trials. Primary prevention statin trials. Secondary prevention statin trials. Other trials. Normal Lipid Values.NCEP/ATP-III GUIDELINES. Review of ATP-III for treatment of hyperlipidemia. Review of 2004 ATP-III update. Review of ATP-IV.LIFESTYLE CHANGES AND NON-DRUG TREATMENT. Weight loss and other diets--benefits and risks. Therapeutic foods. Exercise interventions--benefits and risks.DRUG TREATMENT. General principles of drug treatment of hyperlipidemia. Agents (action, dosing, side effects, unique uses). Drug interactions. Drug intolerance and severe side effects. Drugs of the future.SPECIAL POPULATIONS AND SITUATIONS. Elderly patients .-Patients with multiple medical problems. Women. Adults younger than 35 years of age. Children. Elite athletes. Native Americans. Immigrants. Family issues. Community issues and population health concerns.OTHER ISSUES IN PREVENTION OF CARDIOVASCULAR DISEASE. Aspirin prophylaxis. Novel screening tools for risk assessment.PRACTICAL APPROACH TO THE PATIENT WITH HYPERLIPIDEMIA. Treatment algorithms. Visit and serum testing frequency. Compliance and motivational tools. Referral guidelines for refractory hyperlipidemia.CASE STUDIES. The well elderly patient. The well young patient. The diabetic. The patient with intermediate risk. The unreachable goal. Kids. Normal cholesterol, but high TG and low HDL. Can't use statins. Metabolic syndrome.FUTURE DIRECTIONS. How low do you go? PPARs and prevention of metabolic syndrome. Integrative treatment (diet + exercise + drugs).